Analysis of epithelial heterogeneity in prostate development and cancer
Analysis of epithelial heterogeneity in prostate development and cancer
批准号:
10378051
负责人:
MICHAEL M. SHEN
金额:
$41.1万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-04-01 至 2024-03-31
关键词:
3-DimensionalAddressAdultBenignBioinformaticsBiological MarkersBiometryCancer PrognosisCellsClinicalDataData AnalysesDevelopmentDisease OutcomeEpithelialEpithelial CellsGenesGenetic TranscriptionGenetically Engineered MouseGenitourinary systemGleason Grade for Prostate CancerHeterogeneityHomeostasisHumanIndolentInvestigationKidney TransplantationLaboratoriesLeadMalignant NeoplasmsMalignant neoplasm of prostateMethodologyModelingMolecularMolecular AnalysisMolecular ComputationsMolecular ProfilingMusNeurosecretory SystemsNormal tissue morphologyOncogenicOncologyOrganoidsPathologyPhenotypePlayPopulationPositioning AttributeProcessPropertyProstateProstatic NeoplasmsResearchRoleSpecific qualifier valueSystemSystems BiologyTherapeuticTissuesUrologyValidationVisualizationbasebiomarker identificationcancer initiationcell typeimprovedin vivoinnovationinsightnovelpotential biomarkerprogenitorprogramsprostate cancer cellprostate cancer modelprostate carcinogenesissingle cell analysissingle-cell RNA sequencingstemstem cellstherapeutic targettranscriptomicstranslational impacttreatment responsetumortumor heterogeneitytumor progressiontumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The cell type that undergoes cancer initiation, or “cell of origin,” plays a key role in determining tumor
properties such as molecular and histopathological subtype as well as treatment response and disease
outcome. In the case of prostate cancer, the cell of origin may be highly relevant for whether it is indolent or
aggressive, and consequently the analysis of cell types of origin may lead to identification of biomarkers that
can guide therapy. Over the past ten years, our laboratory has made considerable progress in understanding
prostate cell types of origin through studies of the progenitor populations, lineage relationships, and
transcriptional regulators of the prostate epithelium during normal development as well as cancer initiation and
progression. In preliminary studies for this proposal, we have performed single-cell RNA sequencing to
examine the heterogeneity of prostate epithelial cells in the benign mouse and human prostate. Notably, these
analyses have revealed several different luminal populations that have not been previously identified, and may
represent distinct cell types of origin. Furthermore, we have used computational systems approaches to
identify candidate master regulator (driver) genes for these novel luminal populations. Finally, we have
established three-dimensional organoid culture conditions to investigate whether specific mouse and human
epithelial cell populations are cell types of origin for prostate cancer.
Based on our preliminary data, we hypothesize that analysis of the origin and drivers of specific
epithelial populations in the prostate will elucidate cell types of origin for prostate cancer as well as their roles
in specifying tumor phenotypes. To investigate this hypothesis, we will pursue an innovative combination of in
vivo, ex vivo, molecular, and computational systems approaches using genetically-engineered mouse models
and human prostate tissue. We propose three specific aims: (1) Investigation of epithelial heterogeneity in the
developing and adult prostate using single-cell transcriptomics to examine the origin and lineage relationships
of distinct epithelial populations and identify drivers that specify these populations; (2) Analysis of cell of origin
in mouse and human prostate using organoid culture approaches to determine whether distinct luminal and
basal epithelial populations can give rise to tumors after oncogenic transformation and identify candidate
master regulators of this process; and (3) Investigation of epithelial heterogeneity in mouse and human
prostate cancer using cross-species single-cell analyses to identify conserved drivers of tumor heterogeneity.
Taken together, our studies will provide fundamental molecular and functional insights into prostate epithelial
heterogeneity during development and tumorigenesis, and will have important implications for understanding
the origins of human prostate cancer and its treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 3: Analysis of intrinsic and extrinsic factors that promote prostate neuroendocrine differentiation
-
批准号:10612357
-
项目类别:
-
资助金额:$42.67万
-
财政年份:2022
-
负责人:MICHAEL M. SHEN
-
依托单位:
Core B: Administrative and Data Management Core
-
批准号:10333946
-
项目类别:
-
资助金额:$52.55万
-
财政年份:2022
-
负责人:MICHAEL M. SHEN
-
依托单位:
Project 3: Analysis of intrinsic and extrinsic factors that promote prostate neuroendocrine differentiation
-
批准号:10333945
-
项目类别:
-
资助金额:$63.91万
-
财政年份:2022
-
负责人:MICHAEL M. SHEN
-
依托单位:
Investigating cell-intrinsic and extrinsic interactions in prostate cancer at the single cell level
-
批准号:10612346
-
项目类别:
-
资助金额:$205.58万
-
财政年份:2022
-
负责人:MICHAEL M. SHEN
-
依托单位:
Core B: Administrative and Data Management Core
-
批准号:10612361
-
项目类别:
-
资助金额:$25.36万
-
财政年份:2022
-
负责人:MICHAEL M. SHEN
-
依托单位:
Investigating cell-intrinsic and extrinsic interactions in prostate cancer at the single cell level
-
批准号:10333942
-
项目类别:
-
资助金额:$305.25万
-
财政年份:2022
-
负责人:MICHAEL M. SHEN
-
依托单位:
Genetic Approaches to Development and Disease
-
批准号:10206946
-
项目类别:
-
资助金额:$39.01万
-
财政年份:2021
-
负责人:MICHAEL M. SHEN
-
依托单位:
Investigating lineage plasticity in castration-resistant prostate cancer
-
批准号:10441364
-
项目类别:
-
资助金额:$41.93万
-
财政年份:2020
-
负责人:MICHAEL M. SHEN
-
依托单位:
Investigating lineage plasticity in castration-resistant prostate cancer
-
批准号:10656234
-
项目类别:
-
资助金额:$41.93万
-
财政年份:2020
-
负责人:MICHAEL M. SHEN
-
依托单位:
Investigating lineage plasticity in castration-resistant prostate cancer
-
批准号:10033614
-
项目类别:
-
资助金额:$42.79万
-
财政年份:2020
-
负责人:MICHAEL M. SHEN
-
依托单位:
Investigating lineage plasticity in castration-resistant prostate cancer
-
批准号:10164741
-
项目类别:
-
资助金额:$42.79万
-
财政年份:2020
-
负责人:MICHAEL M. SHEN
-
依托单位:
Analysis of epithelial heterogeneity in prostate development and cancer
-
批准号:10599886
-
项目类别:
-
资助金额:$41.19万
-
财政年份:2019
-
负责人:MICHAEL M. SHEN
-
依托单位:
Core B: Bladder Cancer Models Core
-
批准号:10475026
-
项目类别:
-
资助金额:$18.52万
-
财政年份:2018
-
负责人:MICHAEL M. SHEN
-
依托单位:
Core B: Bladder Cancer Models Core
-
批准号:10218083
-
项目类别:
-
资助金额:$20.17万
-
财政年份:2018
-
负责人:MICHAEL M. SHEN
-
依托单位:
Project 3: Modeling tumor evolution and drug response in bladder cancer organoids
-
批准号:10475018
-
项目类别:
-
资助金额:$28.9万
-
财政年份:2018
-
负责人:MICHAEL M. SHEN
-
依托单位:
Project 3: Modeling tumor evolution and drug response in bladder cancer organoids
-
批准号:10218080
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2018
-
负责人:MICHAEL M. SHEN
-
依托单位:
Systems analysis of mouse gastrulation
-
批准号:9906071
-
项目类别:
-
资助金额:$33.04万
-
财政年份:2016
-
负责人:MICHAEL M. SHEN
-
依托单位:
Systems analysis of mouse gastrulation
-
批准号:9312134
-
项目类别:
-
资助金额:$33.04万
-
财政年份:2016
-
负责人:MICHAEL M. SHEN
-
依托单位:
Modeling human prostate cancer by cellular reprogramming
-
批准号:9107829
-
项目类别:
-
资助金额:$20.88万
-
财政年份:2015
-
负责人:MICHAEL M. SHEN
-
依托单位:
Molecular mechanisms of prostate cancer initiation
-
批准号:8538769
-
项目类别:
-
资助金额:$124.73万
-
财政年份:2011
-
负责人:MICHAEL M. SHEN
-
依托单位:
海外基金